Magnetic resonance imaging of the inner ear after both intratympanic and intravenous gadolinium injections

Acta Oto-Laryngologica

Volumn 133, Issue 5, 2013, Pages 434-438

  Iida, Tatsuo ^a   Teranishi, Masaaki ^a   Yoshida, Tadao ^a   Otake, Hironao ^a   Sone, Michihiko ^a   Kato, Masahiro ^a   Shimono, Mariko ^a   Yamazaki, Masahiro ^b   Naganawa, Shinji ^b   Nakashima, Tsutomu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Asymptomatic endolymphatic hydrops; Gadolinium contrast agents; Meniere's disease; Signal intensity

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COCHLEA; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; INNER EAR; MALE; MENIERE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SCALA TYMPANI;

ADULT; AGED; CONTRAST MEDIA; EAR, INNER; ENDOLYMPHATIC HYDROPS; FEMALE; GADOLINIUM DTPA; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TYMPANIC MEMBRANE;

EID: 84878033108     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2012.753640     Document Type: Article

References (20)

1. Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, et al. Visualization of endolymphatic hydrops in patients with Meniere's disease. Laryngoscope 2007;117:415-20.
2. Pyykko I, Zou J, Poe D, Nakashima T, Naganawa S. Magnetic resonance imaging of the inner ear in Meniere's disease. Otolaryngol Clin North Am 2010;43:1059-80.
3. Gurkov R, Flatz W, Louza J, Strupp M, Krause E. In vivo visualization of endolymphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol 2011;268:1743-8.
4. Nakashima T, Sone M, Teranishi M, Yoshida T, Terasaki H, Kondo M, et al. A perspective from magnetic resonance imaging findings of the inner ear: relationships among cerebrospinal, ocular and inner ear fluids. Auris Nasus Larynx 2012;39:345-55.
5. Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T. Individual differences in the permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30: 645-8.
6. Crane BT, Minor LB, Della Santina CC, Carey JP. Middle ear exploration in patients with Méniére's disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol 2009;30:619-24.
7. Nakashima T, Naganawa S, Teranishi M, Tagaya M, Nakata S, Sone M, et al. Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Meniere's disease. Acta Otolaryngol 2010;130:338-43.
8. Naganawa S, Kawai H, Sone M, Nakashima T. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010;9:73-80.
9. Sano R, Teranishi M, Yamazaki M, Isoda H, Naganawa S, Sone M, et al. Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection. Acta Otolaryngol 2012;132:241-6.
10. Fukuoka H, Takumi Y, Tsukada K, Miyagawa M, Oguchi T, Ueda H, et al. Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Meniere's disease. Acta Otolaryngol 2012;132:141-5.
11. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74-81.
12. Nakashima T, Naganawa S, Pyykko I, Gibson WP, Sone M, Nakata S, et al. Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009; 560:5-8.
13. Suzuki H, Teranishi M, Sone M, Yamazaki M, Naganawa S, Nakashima T. Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents. Acta Otolaryngol 2011;131: 1025-31.
14. Yamazaki M, Naganawa S, Kawai H, Sone M, Nakashima T. Gadolinium distribution in cochlear perilymph: differences between intratympanic and intravenous gadolinium injection. Neuroradiology 2012;54:1161-9.
15. Claes G, Van den Hauwe L, Wuyts F, Van de Heyning P. Does intratympanic gadolinium injection predict efficacy of gentamicin partial chemolabyrinthectomy in Meniere's disease patients? Eur Arch Otorhinolaryngol 2012;269:413-18.
16. Fiorino F, Pizzini FB, Barbieri F, Beltramello A. Variability in the perilymphatic diffusion of gadolinium does not predict the outcome of intratympanic gentamicin in patients with Meniere's disease. Laryngoscope 2012;122:907-11.
17. Suzuki H, Teranishi M, Naganawa S, Nakata S, Sone M, Nakashima T. Contrast-enhanced MRI of the inner ear after intratympanic injection of meglumine gadopentetate or gadodiamide hydrate. Acta Otolaryngol 2011;131:130-5.
18. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolymphatic hydrops in Meniere's disease with single-dose intravenous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci 2010;9:237-42.
19. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of endolymphatic and perilymphatic fluid after intravenous administration of single dose gadodiamide. Magn Reson Med Sci 2012;11:145-50.
20. Tagaya M, Yamazaki M, Teranishi M, Naganawa S, Yoshida T, Otake H, et al. Endolymphatic hydrops and blood-labyrinth barrier in Meniere's disease. Acta Otolaryngol 2011;131:474-9.